Soyon Lee

Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation

Soyon Lee, Moise Anglade, Robyn Pisacane et al. · The American Journal of Cardiology · 2012 · 129 citations

Medicine, Pharmacoeconomics, Pharmacotherapy +14

Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation

Soyon Lee, Rachel Mullin, Jon Blazawski et al. · PLoS ONE · 2012 · 66 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States

Soyon Lee, Daniel C. Baxter, Brendan Limone et al. · Journal of Medical Economics · 2012 · 42 citations · Full text

Pharmacy, Neurology, Pharmacoeconomics +17

<p>Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review</p>

Soyon Lee, Diana K. Vania, Menaka Bhor et al. · International Journal of General Medicine · 2020 · 41 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17

Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin

Soyon Lee, Moise Anglade, Joy Meng et al. · Circulation Cardiovascular Quality and Outcomes · 2012 · 39 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17